ArticleCureus2026
The Role of 68Ga-Pentixafor and 18F-Fluorodeoxyglucose (18F-FDG) PET/CT in a Case of Multiple Myeloma.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple myeloma (MM) is a type of blood cancer affecting plasma cells in the bone marrow. The diagnosis of MM involves blood and urine tests to demonstrate monoclonal proteins. Imaging modalities such as MRI combined with positron emission tomography (PET) are used for the detection and staging of MM. 18F-fluorodeoxyglucose (18F-FDG) has been used extensively for the staging of multiple myeloma. Another PET imaging modality targeting C-X-C chemokine receptor type 4 (CXCR4) has been recently evaluated for the staging of MM. CXCR4 is a protein receptor expressed on plasma cells, and the radiolabelled Pentixafor radiotracer targets these receptors and is therefore used in PET imaging. In this case report, we compare FDG and CXCR4 PET radiotracers for staging MM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.